Endometrial cancer: asymptomatic endometrial findings. Characteristics of postmenopausal endometrial cancer

被引:0
作者
Marchetti, A [1 ]
Vasile, C [1 ]
Chiarelli, S [1 ]
机构
[1] Univ Padua, Dept Pathol, I-35100 Padua, Italy
关键词
endometrial cancer; elderly patients; asymptomatic findings;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Endometrial cancer affects patients at every age, however it occurs more frequently in menopause (> 50) and in postmenopause (> 70). The most frequent symptoms are bleeding and vaginal discharge. When hematometra or pyonietra is present the patient may feel pain. In some cases endometrial adenocarcinoma is asymptomatic and the diagnosis is casually made during ultrasound examination or by histological examination of a uterus surgically removed for other indications. In these cases the most frequent findings are polyps and abnormally increased thickness of the endometrial mucosa. In postmenopause polyps and abnormal endometrial thickness are usually limited to a small area and surrounded by atrophic mucosa. Higher incidence rates of endometrial cancer were con-elated with polyps and an increased number of serous type tumors were identified in the > 65-year age group. Endometrial carcinoma may be estrogen correlated or non-estrogen associated. Patients in postmenopause are often affected by non-estrogen con-elated endometrial carcinoma. According to Kurman and other authors the first type of endometrial adenocarcinoma (estrogen correlated) is characterized by low-grade malignancy. On the contrary, non-estrogen correlated neoplasia is more aggressive. In our case series including 102 women aged > 70 years with endometrial carcinoma we found that survival was correlated with stage and grading - early stages were the most frequent and the grade increased with stage. In fact all the patients with relapses had grade 2 or 3 adenocarcinomas. Thirty-one patients > 70 years (30.69%) had a non-endometrioid type of cancer.
引用
收藏
页码:479 / 484
页数:6
相关论文
共 50 条
[1]  
Anastasiadis PG, 2000, EUR J GYNAECOL ONCOL, V21, P180
[2]  
Bellino R, 2001, ANTICANCER RES, V21, P3721
[3]   Risk and prognosis of endometrial cancer after tamoxifen for breast cancer [J].
Bergman, L ;
Beelen, MLR ;
Gallee, MPW ;
Hollema, H ;
Benraadt, J ;
van Leeuwen, FE .
LANCET, 2000, 356 (9233) :881-887
[4]   Sonographic control of the endometrium under tamoxifen:: Really not useful? [J].
Burkart, C ;
Wight, E ;
Pók, J ;
Kernen, B ;
Traber, M ;
Haller, U ;
Bajka, M .
ULTRASCHALL IN DER MEDIZIN, 2001, 22 (03) :136-142
[5]   Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment [J].
Ciatto, S ;
Cecchini, S ;
Gervasi, G ;
Landini, A ;
Zappa, M ;
Crocetti, E .
BRITISH JOURNAL OF CANCER, 2003, 88 (08) :1175-1179
[6]   Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients [J].
Cohen, I ;
Bernheim, J ;
Azaria, R ;
Tepper, R ;
Sharony, R ;
Beyth, Y .
GYNECOLOGIC ONCOLOGY, 1999, 75 (01) :136-141
[7]   Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer [J].
Deligdisch, L ;
Kalir, T ;
Cohen, CJ ;
de Latour, M ;
Le Bouedec, G ;
Penault-Llorca, F .
GYNECOLOGIC ONCOLOGY, 2000, 78 (02) :181-186
[8]   Endometrial cancer: The potential role of cervical cytology in current surgical staging [J].
DuBeshter, B ;
Deuel, C ;
Gillis, S ;
Glantz, C ;
Angel, C ;
Guzick, D .
OBSTETRICS AND GYNECOLOGY, 2003, 101 (03) :445-450
[9]  
Eltabbakh G H, 2001, Expert Opin Pharmacother, V2, P1399
[10]  
FORNANDER T, 1989, LANCET, V1, P117